Xenetic Biosciences, Inc. (XBIO): Price and Financial Metrics
XBIO Price/Volume Stats
| Current price | $4.11 | 52-week high | $5.20 |
| Prev. close | $4.01 | 52-week low | $2.78 |
| Day low | $3.90 | Volume | 9,000 |
| Day high | $4.21 | Avg. volume | 11,439 |
| 50-day MA | $3.91 | Dividend yield | N/A |
| 200-day MA | $3.97 | Market Cap | 6.34M |
XBIO Stock Price Chart Interactive Chart >
Xenetic Biosciences, Inc. (XBIO) Company Bio
Xenetic Biosciences, Inc. operates as a biopharmaceutical company. The Company focuses on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens, as well as offers cell-based therapeutics targeting the B-cell receptor on the surface of malignant tumor cells. Xenetic Biosciences serves patients in the United States.
XBIO Price Returns
| 1-mo | 10.78% |
| 3-mo | -4.42% |
| 6-mo | N/A |
| 1-year | 34.75% |
| 3-year | -72.23% |
| 5-year | -64.57% |
| YTD | 19.13% |
| 2023 | 21.01% |
| 2022 | -77.90% |
| 2021 | -36.76% |
| 2020 | 41.67% |
| 2019 | -92.68% |
Loading social stream, please wait...